Meningitis is an infection characterized by the inflammation of meninges. The meninges are the three layer of protective tissue consisting of dura mater, arachnoid mater, and pia mater that surround the neuraxis. Neuraxis represents the direction in which the central nervous system lies. The most common causes of meningitis are bacteria and viruses and less common causes include parasites and fungi. The symptoms of meningitis include, severe headache, vomiting, fever, stiff neck, sensitivity to light, and distinctive skin rash. Meningitis caused by bacteria is more severe than that by virus. It is challenging to diagnose meningitis as it shows most common symptoms. Meningitis can be diagnosed by performing blood test to check for the presence of bacteria or viruses that can cause the disease. Lumbar puncture can also be performed in which cerebrospinal fluid (CSF) is taken from the base of the spine and checked for the presence of bacteria or viruses. Bacterial meningitis can be treated with a combination of several antibiotics.
Meningitis Diagnostic Testing Market Drivers
Development of novel technologies that require less time in diagnosis of meningitis is a major factor for meningitis diagnostic testing market growth. For instance, in April 2018, Ireland-based firm — HiberGene Diagnostics— introduced ‘HG Meningococcus test’— a combination test for meningococcal and pneumococcal meningitis that offers accurate results in as little as 40 minutes. The new test is expected to cover 90% cases of bacterial meningitis and help to speed up treatment of the illness.
Furthermore, increasing research and development activities to diagnose various type of meningitis is expected to boost growth of the meningitis diagnostic testing market during the forecast period. For instance, in July 2018, Antrum Biotech and the University of Cape Town developed a new rapid test that can diagnose tuberculosis (TB) meningitis within two hours. The test is currently undergoing validation to enter the market.
Meningitis Diagnostic Testing Market- Regional Analysis
However, lack of access to newer diagnostics technology by people in low income countries may restrain growth of the market. Moreover, lack of diagnostic laboratory infrastructure in developing countries is one of the major restraint for the Meningitis Diagnostic Testing Market. Nevertheless, this can be improved by using test that do not require laboratory support including rapid tests for use at the point-of-care.
On the basis of region, the global meningitis diagnostics testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America is expected to hold dominant position in the global meningitis diagnostic testing market over the forecast period, owing to early adoption of diagnostic technologies by the major players. Moreover, major players in the North America meningitis diagnostic testing market are focused on adopting acquisition and collaboration strategies to enhance their market share. This in turn is expected to boost the market growth. For instance, in September 2018, Quest Diagnostics acquired the U.S. laboratory services business of Oxford Immunotec. This acquisition is expected to expand capabilities of Quest Diagnostics in infectious disease diagnostics to accelerate growth of the company by increasing access to diagnostic innovation.
Furthermore, presence of key players in Asia Pacific is expected to increase growth of the meningitis diagnostics testing market in the region. For instance, in May 2017 Seegene Inc., announced that it has entered into a new strategic collaboration agreement with India-based Thermo Fisher Scientific. The collaboration was filed to the U.S Food and Drug Administration (FDA) for clearance of AllplexTM diagnostic assay by Seegene Inc. Thermo Fisher filed for U.S.FDA clearance to run Seegene’s assays on Thermo Fisher’s QuantStudio 5 Real-Time PCR System.
Increasing prevalence of meningitis in Africa is expected to contribute to significant growth of the meningitis diagnostics market in the region. For instance, according to a report by World Health Organization (WHO), February 2018, major epidemics of meningococcal disease have occurred within the African meningitis belt (Lapeysonnie). These epidemics are very disruptive, requiring the establishment of emergency treatment centers to offer proper treatment to the patients in the region.
Some of the key players operating in the market include, Thermo Fisher Scientific, Inc., BioFire Diagnostics, Siemens, Quest Diagnostics, Bio-Rad Laboratories, Inc., Luminex Corporation, Seegene Inc., IMMY, ELITechGroup, Abbott, Pfizer, Nuron Biotech, GSK, MedImmune, Sanofi, Novartis, Baxter, Merck & Co., Biomed Pvt. Ltd, and others.
Meningitis Diagnostic Testing Market Taxonomy
By Infection Type
By Test Type
By End User
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.